Feature | September 05, 2013

The rate at which women get called back for additional imaging after screening mammography may be higher at hospitals than at community office practices, mostly due to differences among the patients, according to a new study published online in the journal Radiology. The findings highlight the limitations of recall rates as a quality measure for breast cancer screening, the researchers said.

Recall rates for mammography refer to the percentage of women who undergo screening and are called back for additional testing. Since recalls involve anxiety for patients and additional costs, there have been efforts to keep these rates as low as possible. “Recall rate by itself is used as a quality indicator by the federal government,” said Ana Lourenco, M.D., radiologist at the Rhode Island Hospital and the Alpert School of Medicine at Brown University in Providence, R.I. “Therefore, it remains important to understand the factors that influence recall rate for individuals and practices.”

To better understand these factors, Lourenco and colleagues reviewed data between May 2008 and September 2011 for five radiologists with expertise in breast imaging who interpreted mammograms at a community office practice and an academic referral hospital. Both sites utilized full-field digital mammography and batch screening interpretation.

The radiologists interpreted a total of 74,297 screening mammograms between both sites during the study. The total number of patients recalled was 5,799, for an overall recall rate of 7.8 percent. At 6.9 percent, the recall rate at the community site was significantly lower than the hospital rate of 8.6 percent. “For every radiologist, the recall rate was significantly lower in community practice than in the hospital setting,” noted Lourenco.

When the researchers compared the two groups of patients, they found some important differences that could have influenced recall rates. Significantly more of the hospital patients had undergone previous surgeries and biopsies. Slightly more than 13 percent of the patients at the hospital site had a history of surgery, compared with 5.6 percent at the community site, and 7 percent of patients at the hospital had undergone a biopsy, compared with 1.4 percent at the community site. “These patients may have more complicated mammograms to interpret or may be at higher risk for cancer than patients at the community site,” Lourenco said. “Higher risk patients would be expected to increase the recall rate of the population.”

Another key factor was the age of the patients. The mean age of the patients at the hospital site was 56 years, compared with a mean age of 63 years at the private practice. “Younger age has been associated with higher recall rates,” Lourenco said.

While Lourenco commended efforts to develop quality metrics for breast cancer screening, she cautioned that recall rates are affected by factors out of the radiologist’s control and, therefore, cannot alone determine the quality of a radiologist or an institution.

For more information: RadiologyInfo.org


Related Content

News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
News | Artificial Intelligence

Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...

Time December 02, 2024
arrow
Subscribe Now